Publications by authors named "Jonathan A Robbins"

Claim this Profile
M
MK-7602: a potent multi-stage dual-targeting antimalarial.
Paola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, Wendy Bailey, Christopher W Boyce, Jonathan A Robbins

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data.
Johannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, Shiuli Agarwal, Garrett Nieddu, Jonathan A Robbins

Immunohorizons· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial.
Jonathan A Robbins, Scott Sands, Lata Maganti, Tami Crumley, Sabrina Fox-Bosetti

J Clin Sleep Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the inhibitory effects of itraconazole on letermovir.
Jacqueline B McCrea, Karsten Menzel, Craig Fancourt, Rose Witter, Tian Zhao, Jonathan A Robbins

Br J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.
Jonathan A Robbins, Dereck Tait, Qinlei Huang, Sheri Dubey, Tami Crumley

EBioMedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics.
Jonathan A Robbins, Karsten Menzel, Michael Lassman, Tian Zhao, Craig Fancourt

Clin Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
Paola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, Tony Triglia, Anna Ngo, Jonathan A Robbins

Cell Host Microbe· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An APC/C-Cdh1 Biosensor Reveals the Dynamics of Cdh1 Inactivation at the G1/S Transition.
Andrej Ondracka, Jonathan A Robbins, Frederick R Cross

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Malaria Parasite Cyclin H Homolog PfCyc1 Is Required for Efficient Cytokinesis in Blood-Stage .
Jonathan A Robbins, Sabrina Absalon, Vincent A Streva, Jeffrey D Dvorin

mBio· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An essential malaria protein defines the architecture of blood-stage and transmission-stage parasites.
Sabrina Absalon, Jonathan A Robbins, Jeffrey D Dvorin

Nat Commun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulated degradation of the APC coactivator Cdc20.
Jonathan A Robbins, Frederick R Cross

Cell Div· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements and reasons for effective inhibition of the anaphase promoting complex activator CDH1.
Jonathan A Robbins, Frederick R Cross

Mol Biol Cell· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target gene.
Bruce A Hug, Nazia Ahmed, Jonathan A Robbins, Mitchell A Lazar

J Biol Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis